A wearable, behind-the-ear EEG device shows promise for assessing sleep patterns in young people with Dravet syndrome. The device was found to be feasible and effective for monitoring sleep stages in both healthy controls and patients with DS. Despite some difficulty in staging REM sleep compared to traditional EEG, the behind-the-ear EEG device was accurate in detecting various sleep stages. The study suggests that this device could be valuable for monitoring sleep in clinical trials and challenging patient populations. The research was presented at the American Epilepsy Society annual meeting and was funded by UCB Pharma.
Source link
Wearable EEG feasible for measuring sleep in Dravet syndrome
